Skip to content

Reasons for the low participation rate of organ transplanted patients in the skin cancer screening - an European comparison

Reasons for the low participation rate of organ transplanted patients in the skin cancer screening - an European comparison - GNTOPH

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020365
Enrollment
700
Registered
2020-03-31
Start date
2020-04-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin cancer following organ transplantation

Interventions

Group 1: Physicians, who see patients post transplantation and work in transplant centers in Poland, France, Italy, Spain and GB are asked to answer questions in a web-based questionnaire regarding th

Sponsors

Universität Oldenburg Fakultät VI-Medizin und Gesundheitswissenschaften Department für Versorgungsforschung Abteilung Allgemeinmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: physicians who work in the follow-up of organ transplant patients at transplant centers in GB, Italy, Spain, France and Poland

Exclusion criteria

Exclusion criteria: non-physicians who work with organ transplant patients, physicians, who do not work with organ transplant patients, physicians, who do not work in a transplant center

Design outcomes

Primary

MeasureTime frame
Reasons of organ transplant patients, not to take part in the skin cancer screening and the performance of the screening in the transplant centers, found out through a web-based questionnaire.

Secondary

MeasureTime frame
Ways to improve the participation rate of organ transplant patients in the skin cancer screening

Countries

France, Italy, Poland, Spain, United Kingdom

Contacts

Public ContactMerle Grimm

Universität Oldenburg

merle.grimm@uni-oldenburg.de015750444305

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026